FLT4 and breast cancer: Interestingly, ROC analysis determined that the combined expression of VEGFR3 and PLXNA1 on PBMCs could differentiate TNBC cases from other breast cancer subtypes with a high sensitivity and specificity, providing evidence for a TNBC subtype-specific expression in PBMCs.